Editorial: COVID-19 Vaccines Safety Tracking (CoVaST): Part I

Front Public Health. 2023 Feb 24:11:1154500. doi: 10.3389/fpubh.2023.1154500. eCollection 2023.

Miloslav Klugar^{1

2}, Sameh Attia³, Giordano Pérez-Gaxiola⁴, Tina Poklepović Peričić⁵, Janja Marc^{6

7}, Abanoub Riad^{1

2}

¹ Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Center of Excellence, Masaryk University GRADE Centre), Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Brno, Czechia.
² Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia.
³ Department of Oral and Maxilofacial Surgery, Justus-Liebig University of Giessen, Giessen, Germany.
⁴ Department of Evidence Based Medicine, Sinaloa Pediatric Hospital, Cochrane Mexico, Culiacán, Mexico.
⁵ Department of Prosthodontics, Study of Dental Medicine, University of Split School of Medicine, Split, Croatia.
⁶ Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
⁷ Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Ljubljana, Slovenia.

No abstract available

Keywords: COVID-19; VAERS; Vaccine Adverse Event Reporting System; cross-sectional study; side effects; systematic review; vaccination.

Publication types